AI Identifies Potential Drugs to Slow Childhood Dementia

Researchers have utilized AI to identify existing, approved drugs that may effectively slow the progression of childhood dementia, specifically Sanfilippo syndrome.

The study, conducted on lab-grown brain cells, suggests that repurposing these medications could offer a faster path to treatment than traditional drug development.

This breakthrough provides new hope for families affected by the rare and deadly condition, with clinical trials expected to be the next step in validation.